Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 235

Just as the metaverse industry finally began its breakthrough, ChatGPT’s launch in November 2022 proved a technological avalanche. Amid post-pandemic economic pressures, companies pivoted away from metaverse aspirations to AI adoption, seeking immediate returns through automation and virtualization.

Apple’s 2023 entry into the space with Vision Pro VR headset has similarly faced challenges. At $3,499, with limited content and a sparse developer ecosystem, Apple struggles to find its market. Early projections suggest initial production runs of fewer than 400,000 units.

What if we’ve been looking for the metaverse in the wrong places? While Meta, HTC and Sony have so far struggled to establish their vision of a VR-first digital world, gaming platforms like Roblox quietly built what might be the actual metaverse.

Read more | >

The study sheds light on mechanisms that could help humans recover from hearing loss.

A new study from USC Stem Cell scientists reveals how certain animals, such as zebrafish and lizards, can regenerate their hearing by reactivating dormant gene regulators.

The discovery provides insight into the mechanisms that could one day help humans recover from hearing loss and balance disorders.

Led by Tuo Shi, Ksenia Gnedeva, and Gage Crump from the Keck School of Medicine of USC, the research focuses on the inner ear’s two critical cell types: sensory cells, which detect sound, and supporting cells, which provide structural and functional support.

Read more | >

Mike has over 15 years of experience in healthcare, including extensive experience designing and developing medical devices. MedCrypt, Inc.

On October 1, 2024, the Food and Drug Administration (FDA) marked a major milestone in medical device cybersecurity enforcement. This marks one year since the retracted Refuse to Accept (RTA) policy and the full implementation of the Protecting and Transforming Cyber Healthcare (PATCH) Act amendment to the Food, Drug & Cosmetic Act (FD&C). The FDA’s new requirements represent a fundamental shift in the regulatory landscape for medical device manufacturers (MDMs), as cybersecurity is now a non-negotiable element of device development and compliance.

The timing is not coincidental. In 2023, the FDA issued its final guidance entitled “Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions.” This outlined the detailed cybersecurity requirements and considerations that MDMs must address in their submissions, highlighting the security measures in place to gain regulatory approval. With these requirements, the FDA is taking a hard stance: Cybersecurity is a core consideration, with compliance being systematically enforced.

Read more | >

Kaunas University of Technology (KTU), Lithuania researchers, and scientists from Japan have developed a unique nanolaser. Although the dimensions of this laser are so small that its structure can only be seen through a powerful microscope, its potential is vast. With applications in early medical diagnostics, data communication, and security technologies, this invention could also become a key tool for the study of light and matter interactions.

Depending on the application, lasers differ in the way light is amplified and produced, which determines the color of the radiation and the quality of the laser beam.

“Nanolasers are lasers that use structures a million times smaller than a millimeter to generate and amplify light, and the laser radiation is generated in an extremely tiny volume of material,” says Dr. Mindaugas Juodėnas, one of the authors of the invention.

Read more | >

Synchron has developed a Brain-Computer Interface that uses pre-existing technologies such as the stent and catheter to allow insertion into the brain without the need for open brain surgery.

Read the CNET article for more info:
You Might Not Need Open Brain Surgery to Get Mind Control https://cnet.co/3sZ7k67

0:00 Intro.
0:25 History of Brain Chip Implants.
0:44 About Synchron.
0:54 How Synchron implants the interface.
1:55 How brain patterns transmit signals.
2:50 Risks and Concerns.
3:50 Patients and Clinical Testing.
4:25 Brain Health Monitoring.
5:04 Synchron Switch Price.

Never miss a deal again! See CNET’s browser extension 👉 https://bit.ly/3lO7sOU
Check out CNET’s Amazon Storefront: https://www.amazon.com/shop/cnet?tag=lifeboatfound-20.
Follow us on TikTok: / cnetdotcom.
Follow us on Instagram: / cnet.
Follow us on Twitter: / cnet.
Like us on Facebook: / cnet.

#WhatTheFuture #Synchron #BCI

Read more | >

Bacancy is proud to announce the launch of a new AI tool, MedPreGPT, to help doctors with medicine prescriptions. This system enables doctors who all are using it for internal purposes to give accurate prescription recommendations privately without wasting any time. Compared to AI models like ChatGPT, this tool is specially trained with vast medical data and makes relevant suggestions. This innovative tool is made to enhance patient care, reduce human errors, and streamline the prescription process.

Doctors are only humans and they indeed work under intense work pressure and workload. Mistakes can happen in such an environment. Today’s healthcare providers use ChatGPT and Google’s Gemini for medicine recommendations, which is not completely wrong, but those tools might give false information. Bacancy has recognized the problem and found MedPreGPT to give accurate medical prescriptions.

The following are features of MedPreGPT Provides AI-based prescription recommendations according to symptoms and history. It is integrated with electronic health records (EHRs) for workflow ease. It provides multilingual support for healthcare professionals across the world Provides healthcare providers with updates in real time, regarding the latest clinical guidelines and drug interactions to ensure true care.

Read more | >

In a recent study published in Nature Cancer, a team of researchers investigated the unique structure of deoxyribonucleic acid (DNA) in extracellular vesicles (EVs) and its role in cancer progression.

The study examined how EV-DNA, through its association with histones, influences immune cell responses and impacts the pre-metastatic niche. It also explored how it could serve as a predictive biomarker for metastasis, especially in colorectal cancer.

The study highlights how EV-DNA packaging influences immune responses and its promise as a biomarker for assessing colorectal cancer metastasis risk.

Read more | >